Dr. Vinod Raina - Gurgaon

Gurgaon, India

About Dr. Vinod Raina

  • Dr. Vinod Raina is a Medical Oncologist of high acclaim with experience of more than 23 years.
  • Dr. Raina is a member of multiple prestigious associations such as the Indian Society of Oncology, European Society of Medical Oncology and Association of Physicians of India.
  • He spearheaded various clinical trials for breast cancer and has about 200 research publications in the International and National medical journals.
  • Besides, he is the Principal investigator of approximately 50 projects in AIIMS.
  • He offers treatment for breast cancer, lung cancer, blood cancer (Acute and Chronic Leukaemia, Lymphomas), and gastrointestinal cancer.
  • Besides, he does Concurrent Bio- Radiotherapy, Palliative Bio- Chemotherapy, and Paediatric Chemotherapy.
  • The doctor introduced the first high-dose chemotherapy and peripheral blood stem cell transplant in India in 1994.
  • In his career span, he has performed more than 250 Transplantations. Moreover, under his guidance and leadership, the doctors at AIIMs have carried out over 300 transplantations, the highest number of transplants in India in the last 10 years. This includes about 250 allo-transplants.
  • He is the Co-Founder of INDOX Network which is a very successful and popular network.

Specialization

  • Lung cancer
  • Blood cancer (Acute and Chronic Leukaemia, Lymphomas)
  • Gastrointestinal cancer
  • High Dose Chemotherapy
  • Peripheral Blood Stem Cell transplantation
  • Concurrent Bio- Radiotherapy
  • Palliative Bio- Chemotherapy
  • Pediatric Chemotherapy

List Of Treatments

 

  • Chemotherapy
  • Acute Lymphocytic Leukemia – ALL in Adults
  • Breast Biopsy
  • Hairy Cell Leukemia – HCL
  • Metastatic Tumors Treatment
  • Adrenal Cancer Treatment
  • Anal Cancer Treatment
  • Bile Duct Cancer Treatment
  • Bladder Cancer Treatment
  • Breast Cancer-Surgical
  • Cancer in Children
  • Carcinoma of Unknown Primary (CUP) Treatment
  • Castleman Disease Treatment
  • Cervical Cancer Treatment
  • Endometrial Cancer Treatment
  • Esophagus Cancer Treatment
  • Ewing Family of Tumors Treatment
  • Eye Cancer Treatment
  • Gallbladder Cancer Treatment
  • Gestational Trophoblastic Disease (GTD) Treatment
  • Hodgkin Disease Treatment
  • Laryngeal and Hypopharyngeal Cancer Treatment
  • Leukemia in Children
  • Liver Cancer
  • Lung Cancer Treatment
  • Non-Small Cell Lung Cancer (NSCLC) Treatment
  • Small-cell Carcinoma Treatment
  • Lung Carcinoid Tumor Treatment
  • Skin Lymphoma Treatment
  • Malignant Mesothelioma Treatment
  • Nasopharyngeal Cancer Treatment
  • Neuroblastoma
  • Non-Hodgkin Lymphoma (NHL) Treatment
  • Non-Hodgkin Lymphoma In Children
  • Oral Cavity and Oropharyngeal Cancer
  • Ovarian Cancer Surgery
  • Pancreatic Cancer
  • Penile Cancer Treatment
  • Prostate Cancer-Surgical
  • Retinoblastoma (RB) Treatment
  • Rhabdomyosarcoma (RMS) Treatment
  • Salivary Gland Cancer
  • Soft Tissue Sarcoma Treatment
  • Skin Cancer
  • Skin Cancer – Melanoma
  • Stomach Cancer Treatment
  • Testicular Cancer Treatment
  • Thymoma and Thymic Carcinoma Treatment
  • Thyroid Cancer Treatment
  • Uterine Sarcoma
  • Vaginal Cancer Treatment
  • Vulvar Cancer Treatment
  • Waldenstrom Macroglobulinemia
  • Wilms Tumor (Nephroblastoma)
  • Oral Cancer – Surgical
  • Breast Cancer
  • Leukemia Treatment
  • Fallopian Tube Cancer
  • Ovarian Germ Cell Tumor
  • Ovarian Primary Peritoneal Cancer
  • Medullary Carcinoma
  • Papillary Thyroid Cancer Treatment
  • Ovarian Sex Cord Stromal Tumor
  • Invasive Lobular Carcinoma
  • Colon Cancer Treatment
  • Adenocarcinoma – Glandular Cancer Treatment
  • Immunotherapy
  • Radiotherapy
  • IMRT
  • Small Intestine Cancer Treatment
  • Bone Marrow Cancer
  • Cancer Treatment
  • Breast Conservation Surgery – BCS
  • Breast Lumpectomy

 

Work Experience

  • H. O.D, Rotary Section, Institute Rotary Cancer Hospital, AIIMS
  • H. O.D, Medical Oncologist, Royal Hospital, Cancer Centre, Muscat, Oman, 2004
  • Honorary Research Fellow. Medical Oncology, Oxford University, UK, 2010
  • H. O. D, Delhi, Cancer Registry, All India Institute of Medical Sciences (AIIMS), 2010
  • H. O. D, Medical Oncology, All India Institute of Medical Sciences (AIIMS), 2013
  • Professor, H. O. D, Medical Oncologist, All India Institute of Medical Sciences (AIIMS), 2013
  • Director, Fortis Memorial Research Institute, Gurgaon

Education

  • MBBS, 1974, All India Institute of Medical Sciences, New Delhi
  • MD, 1977, Internal Medicine, All India Institute of Medical Sciences, New Delhi
  • DM, 1984, Medical Oncology, All India Institute of Medical Sciences
  • MRCP, UK
  • FRCP, London and Edinburg

Book An Appointment

    Copyright © 2021 IMA | All Rights Reserved.